Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Prion (PRNP)

  • Rafael Linden
  • Vilma R. Martins
  • Marco A. M. Prado
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_390

Synonyms

 CD230;  Prion protein;  Prn-i;  Prnp;  Prn-p;  PrP;  PrpC;  PrPC;  PrPSc;  Sinc

Historical Background

Transmissible spongiform encephalopathies (TSEs) are neurodegenerative diseases characterized by neuron loss, glial reactions, and tissue spongiosis, which course with motor and/or cognitive symptoms. The TSEs are associated with conformational conversion of the prion protein (PrPC, the product of the Prnp gene), wherein the predominantly α-helical secondary structure of PrPC changes into an aggregation-prone, β-sheet-rich structure known as PrPSc. The latter is believed to coerce PrPC molecules into conformational conversion, thus behaving as a proteinaceous infectious particle, or prion, which gave TSEs the epithet prion diseases (Colby and Prusiner 2011).

The much needed development of effective treatment for these still incurable diseases depends on the understanding of functional properties of the prion protein. Most studies of physiological functions of PrPChave been...

This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

The authors’ research groups have been supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Programa Institutos Nacionais de Ciência e Tecnologia (CNPq/MCT), Canadian Institutes of Health Research (CIHR), the Weston Brain Institute, Brain Canada, The Alzheimer’s Association (USA), The Alzheimer’s Society (Canada), and PrioNet-Canada. V.R.M. is an International Scholar of the Howard Hughes Medical Institute.

References

  1. Beckman D, Linden R. A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease. Prion. 2016;10(2):131–42.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Beraldo FH, Soares IN, Goncalves DF, Fan J, Thomas AA, Santos TG, et al. Stress-inducible phosphoprotein 1 has unique cochaperone activity during development and regulates cellular response to ischemia via the prion protein. FASEB J. 2013;27(9):3594–607.CrossRefPubMedGoogle Scholar
  3. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, et al. Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci. 2010;13(3):310–8.CrossRefPubMedGoogle Scholar
  4. Caetano FA, Beraldo FH, Hajj GN, Guimaraes AL, Jurgensen S, Wasilewska-Sampaio AP, et al. Amyloid-beta oligomers increase the localization of prion protein at the cell surface. J Neurochem. 2011;117(3):538–53.CrossRefPubMedGoogle Scholar
  5. Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol. 2011;3(1):a006833.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Isaacs JD, Jackson GS, Altmann DM. The role of the cellular prion protein in the immune system. Clin Exp Immunol. 2006;146(1):1–8.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Linden R, Martins VR, Prado MAM, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev. 2008;88(2):673–728.CrossRefPubMedGoogle Scholar
  8. Linden R, Cordeiro Y, Lima LM. Allosteric function and dysfunction of the prion protein. Cell Mol Life Sci. 2012;69(7):1105–24.CrossRefPubMedGoogle Scholar
  9. Martins VR, Beraldo FH, Hajj GN, Lopes MH, Lee KS, Prado MM, et al. Prion protein: orchestrating neurotrophic activities. Curr Issues Mol Biol. 2010;12(2):63–86.PubMedGoogle Scholar
  10. Mehrpour M, Codogno P. Prion protein: from physiology to cancer biology. Cancer Lett. 2010;290(1):1–23.CrossRefPubMedGoogle Scholar
  11. Nitta K, Sakudo A, Masuyama J, Xue G, Sugiura K, Onodera T. Role of cellular prion proteins in the function of macrophages and dendritic cells. Protein Pept Lett. 2009;16(3):239–46.CrossRefPubMedGoogle Scholar
  12. Nuvolone M, Hermann M, Sorce S, Russo G, Tiberi C, Schwarz P, et al. Strictly co-isogenic C57BL/6J-Prnp−/− mice: a rigorous resource for prion science. J Exp Med. 2016;213(3):313–27.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Prado MAM, Alves-Silva J, Magalhaes AC, Prado VF, Linden R, Martins VR, et al. PrPc on the road: trafficking of the cellular prion protein. J Neurochem. 2004;88(4):769–81.CrossRefPubMedGoogle Scholar
  14. Rutishauser D, Mertz KD, Moos R, Brunner E, Rulicke T, Calella AM, et al. The comprehensive native interactome of a fully functional tagged prion protein. PLoS One. 2009;4(2):e4446.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Steinacker P, Hawlik A, Lehnert S, Jahn O, Meier S, Gorz E, et al. Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis. Am J Pathol. 2010;176(3):1409–20.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Stella R, Massimino ML, Sandri M, Sorgato MC, Bertoli A. Cellular prion protein promotes regeneration of adult muscle tissue. Mol Cell Biol. 2010;30(20):4864–76.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Um JW, Strittmatter SM. Amyloid-beta induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion. 2013;7(1):37–41.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron. 2013;79(5):887–902.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Weissmann C, Fischer M, Raeber A, Bueler H, Sailer A, Shmerling D, et al. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies. Rev Sci Tech. 1998;17(1):278–90.CrossRefPubMedGoogle Scholar
  20. Wuthrich K, Riek R. Three-dimensional structures of prion proteins. Adv Protein Chem. 2001;57:55–82.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Rafael Linden
    • 1
  • Vilma R. Martins
    • 2
  • Marco A. M. Prado
    • 3
  1. 1.Laboratorio de NeurogeneseInstituto de Biofisica da UFRJRio de JaneiroBrazil
  2. 2.International Research CenterA.C. Camargo Cancer CenterSão PauloBrazil
  3. 3.Department of Physiology and Pharmacology and Anatomy and Cell Biology, Schulich School of MedicineUniversity of Western OntarioLondonCanada